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Abstract  
Introduction: sustained viral suppression using antiretroviral treatment (ART) occurs with adherence to treatment of at least 95%. Non-adherence 
promotes the development of drug-resistance and treatment failure in individuals infected with Human Immunodeficiency Virus. In Limpopo Province, 
the adherence rate is approximately 61%, but the prevalence and the factors associated with adherence at Letaba hospital HIV clinic are not well 
established. Therefore, the aim of this study was to identify the factors associated with adherence among HIV-infected young adults, aged 18-35 
years, attending the clinic. Methods: a cross-sectional survey was conducted in Letaba HIV clinic among young adults of 18-35 years old. Logistic 
regression analysis was performed to determine factors associated with ART adherence. We reported odds ratios with the corresponding 95% 
confidence intervals and p-values. A p-value < 0.1 was considered as statistically significant. ART adherence was defined as taking more than 95% 
of the prescribed treatment, 3 days prior to completion of the questionnaire. Results: a total of 281 participants were enrolled with 163 (58.0%) 
females and more than three quarter, 222 (79.0%) between the ages of 18 and 29 years. The overall ART adherence stood at (87.2%) (95% CI: 
63.0%-89.0%) representing 245 participants. Non-adherers to treatment, 36 (12.8%): patients reported no reason (3.9%), forgetting (3.2%), feeling 
good (3.2%), fear and running out of treatment (2.5%) as some of the reasons for not taking treatment within the three days prior to data collection. 
The following factors: tertiary education (p = 0.07), age (30-35; p-value: 0.07), drug availability (p-value: 0.07), were only marginally significantly 
associated with ART adherence. Conclusion: the study found unsatisfactory ART adherence among our participants. Our study suggests that factors 
other than sociodemographic and clinical factors might better explain differences in adherence. This highlights the need for a more complex study 
that would look at the entire system in which these patients are navigating as well as their mental models. 
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Human Immunodeficiency Virus (HIV) that causes HIV infection and 
Acquired Immunodeficiency Syndrome (AIDS), remains one of the 
biggest global public health challenge in world history [1]. In 2016, 
approximately 1.8 million adults were newly infected with HIV, 
contributing to an estimated 36.7 million people living with HIV 
globally [2, 3]. Sub-Saharan Africa is the hardest hit, accounting for 
70% of all people living with HIV globally [4]. South Africa has the 
highest number of people living with HIV in the world (7.06 million) 
and approximately 3.9 million adults have access to antiretroviral 
treatment (ART) of which approximately 260,893 are in Limpopo 
Province [5-7]. The roll-out of ART in Limpopo Province started in 
2004 at the regional hospitals and is now freely available at all levels 
of health care facilities run by government and non-governmental 
organisations [7]. Access to ART alone is not enough to achieve the 
maximum health benefits. Patients must adhere to the treatment 
regimens at a rate of at least 95% [8]. The adherence rate to ART in 
Limpopo Province is approximately 61% [9], which is lower than the 
expected adherence rate of 95% as determined by the World Health 
Organization (WHO) [8]. Antiretroviral treatment suppresses the rate 
at which HIV multiplies within the body, making a person less 
susceptible to opportunistic infections as well as prevent the 
transmission of the virus to other individuals [8]. Failure to follow the 
prescribed ART regimen results in the development of drug-resistant 
strains of HIV and affects the immediate health outcome of the 
individual. This poses a threat of treatment failure and a financial 
burden on the health care system because other treatment options 
must be explored [8]. 
  
In 2013, the WHO released the treatment guidelines that stipulated 
that people who are HIV positive must start ART as early as possible, 
with a criterion of CD4 count less than or equal to 500 cells/mm3 
compared to previous recommendation of CD4 count of 350 
cells/mm3 or less [10]. By 2015, the treatment guidelines shifted to 
testing and treatment of anyone infected with HIV [11]. Starting ART 
early, increases the period an individual will be on treatment, and this 
may in addition to other factors impact on treatment adherence 
[12,13]. Previous studies indicated that patients on ART failed to 
reach optimal adherence due to reasons such as stigma, cultural 
beliefs, misinformation, lack of counselling, and travelling long 
distances to health facilities [14-16]. These determinants differ 
depending on social background and setting of individuals [16, 17]. 
HIV primarily affects those in their reproductive years; with 38% of 
the new infections reported in 2014 occurring among those under the 
age of 25 [2]. Recent studies also found that HIV infection is more 
prevalent among young adults between the ages of 18 and 30 years, 
a group which adheres less to ART due to socio-economic barriers 
[18]. The prevalence of adherence to ART and the factors associated 
with adherence among young adults at Letaba hospital HIV clinic are 
not well established and thus raises a public health concern because 
Letaba Hospital HIV clinic is within Mopani District Municipality which 
is the second district in Limpopo Province with the highest number of 
HIV/AIDS cases [9]. Therefore, the aim of this study was to determine 
the prevalence of adherence to ART and to identify the factors 
associated with ART adherence among HIV positive individuals 
attending the Letaba hospital HIV clinic. The findings of this study will 
be used to enhance current adherence programs to ART and establish 
new interventions targeting these determinants in order to increase 





Study design: the study employed a cross-sectional design to collect 
data on prevalence and associated factors influencing adherence to 
ART. 
  
Study population and sample size: HIV-infected young adults 
between the ages 18 and 35 years on ART for three or more months 
were eligible for study participation. Pregnant women were eligible. 
Therefore, based on the current adherence level of 61% in Limpopo 
[9] allowing for a 5% margin of error with 95% confidence interval, 
a sample size of 281 patients was required. From the medical records 
used, the first participant was selected at random, followed by 
systematic random sampling. Every 3rd participant who met the 
inclusion criteria was eligible to participate in the study. 
  
Study measurements and procedures: study participants were 
interviewed by trained research assistants using a structured 
questionnaire that was adapted from the Adult AIDS Clinical Trials 
Group (AACTG) [19]. Questions were formulated to gather the 
relevant information on the determinants of adherence (exposure 
variables) which include: sociocultural and demographic as well as 
patient and environmental factors. The outcome of interest was a 
binary variable defined as good or poor adherence. Patients were 
categorized as poor adherer if he/she missed a pill, or a pill per dose 
3 days prior to the interview and good adherance if otherwise. 
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Data analysis: descriptive statistics including frequency and 
percentages were used to describe the characteristics of study 
participants. Logistic regression analysis was performed to determine 
factors associated with ART adherence. ART adherence was defined 
as taking more than 95% of the prescribed treatment 3 days prior to 
completion of the questionnaire. ART adherence was self-reported. 
We reported odds ratios with the corresponding 95% confidence 
intervals and p-values. A p-value <0.1 was considered as statistically 
significant. Variables that were statistically significant at 15% level of 
significance in the univariate analysis were included in the 
multivariate model. In allowing for such a high level of significance in 
the univariate analysis we wanted to account for the other missing 
contextual factors and as well as the limitations of the study. As 
argued by David Jean Biau et al. [20] it is important to consider a 
level of significance that accounts for the whole context (scientific 
relevance, economic considerations, aims and limitations of the 
studies). Given that HIV itself is a highly sensitive topic, we decided 
not to be so conservative to account for the interplay of social 
desirability in the responses provided by participants, which is one of 
the biggest limitations of this study. 
  
Ethical approval: ethical clearance was obtained from University of 
Stellenbosch (certificate number S16/07/214) and the National Health 
Research Database after approval by the Department of Health, 
Limpopo Province. Written informed consent was obtained from each 





A total of 281 patients participated in the study of which 163 (58.0%) 
were females and 118 (42.0%) were males on ART for a minimum of 
3 months prior to the study. Two hundred and twenty-two (79.0%) 
participants were between the ages 18 and 29 years. One hundred 
and sixty-eight (59.8%) were single, this included the divorced and 
the widowed and 113 (40.2%) were married or cohabitating. Forty-
three (15.3%) never attended school. Most of the participants had 
primary and secondary education 226 (79.9%) and 12 (4.3%) had 
tertiary education. Most (76.5%) of the participants were 
unemployed. Majority of the participants (59.4%) did not receive any 
monthly income while 33.5% and 7.1% earned monthly income of 
less than R2,999 and between R3,000 and R10,000 respectively. Two 
hundred and fifty-three (90.0%) live less than 10km from the clinic, 
therefore they walk or use mini bus taxis to get to the clinic. About 
21.4% and 35.9% of the participants were smoking and taking 
alcohol, respectively (Table 1). 
  
In the assessment of patient-related factors and environmental 
factors, 245 (87.2%) (95% CI: 63.0%-89.0%) participants adhered 
to treatment. There were 190 (67.2%) participants on ART for more 
than two years and 215 (75.8%) had disclosed their HIV status to 
their spouse, family, friends and colleagues. No side effect was 
experienced while on treatment by 250 (89.0%) of the participants. 
Illness, a month prior to the study, was low with 36 (12.8%) reporting 
to have been ill. The participants did not generally use any form of 
reminder to take treatment, only 84 (29.9%) utilised an alarm, a 
certain program on television or friend to remind them to take their 
treatment. Those that did not adhere to treatment 36 (12.8%) 
reported forgetting (3.2%), feeling good (3.2%), fear and running 
out of treatment (2.5%) as some of the reasons for not taking 
treatment in the past three days prior to data collection. The patient 
and health care provider relationships were good with 262 (93.2%) 
of the patients, reporting that they trust and have positive attitudes 
to their health care providers and believe that their HIV statuses will 
be kept confidential (Table 2). In the univariate analysis of factors 
associated with adherence, education (p=0.104), use of reminder to 
take treatment (p=0.142), alcohol consumption (p=0.131), disease 
severity (p=0.084) and drug availability (p=0.066) were significantly 
associated with adherence to ART at 0.1% level of significance 
(Table 3). 
  
A logistic regression model was performed to document the likelihood 
of adherence, using a set of covariates (predictors significant at 15% 
level of significance in the bivariate analysis (Table 4). By allowing for 
such a high level of statistical significance, we accounted for the 
whole context, acknowledging that we did not control for many other 
contextual factors that may affect lack of adherence. Besides, given 
the relatively highly sensitive nature of the topic, we expected 
participant's responses to suffer from social desirability biases. In the 
bivariate logistic regression model, having a tertiary education (OR: 
6.67; 95% C.I: 1.24−35.71) was statistically associated with 
increased likelihood of failure to adhere to treatment. Although 
factors such as alcohol consumption and use of reminder methods 
were not statistically significant at 10%, we kept them in the 
covariate-adjusted model, since they are relevant factors that have 
been widely reported as factors contributing to non-adherence. The 
other factors including waiting time, attitudes, ART change were 
insignificant at 10% level of significance, thus excluded from the 
multivariate logistic regression model. 
 
Page number not for citation purposes     4 
 
  
Our study found that poor adherence decreased with age, while on 
the other hand, it increased with education (Figure 1). However, the 
overlap between the 95% confidence interval band widths suggests 
that such a difference is not consistently significant and may vanish 
in a larger sample. We found that younger and less educated patients 
were less likely to be poor adherers to treatment compared to older 
educated patients. In addition, we found that older patients (30−35 
years old) were less likely to fail to adhere to treatment (OR: 0.29; 
0.07−1.17) compared to patients less than 25 years of age. Although, 
drug availability showed huge differences (OR: 4.61; 95% C.I.: 
0.68−31.01) in poor adherence among the study participants, 
however, this difference was not statistically significant, because poor 
adherence varied widely among those with medication as well (Figure 
2). We also found that patients lacking drugs with moderate or 
advanced stage of the disease were less likely to be poor adherers, 
compared to similar patients who had access to the drugs. However, 
this difference was not significant because among those with drugs 
at early stage of the diseases, the likelihood of poor adherence varied 
widely, with some probabilities equaling that of patients with no drugs 
(Figure 2). 
  
Finally, we found also that the likelihood of poor adherence varied 
based on the distance that the patients had to travel to the health 
facility (Figure 3). Generally, those close to the health facility were 
less likely to adhere (margins: 0.12). However, such a difference was 
not statistically significant because we also found that adherence 
among those living far from the health facility varied widely with some 





The prevalence of adherence to ART in this study was 87% (95% CI: 
63.0%-89.0%), indicating that 13 in every 100 participants were non-
adherent. This adherence level, is higher than the Limpopo provincial 
rate of 61.0% [9]. This implies that the 13% of the patients with poor 
adherance status were still unsatisfactory when compared to the 
adherence benchmark of 95%, as determined by the WHO, which is 
required for sustained viral load suppression [8]. High adherence to 
ART, which is taking 95% of the prescribed medication, suppresses 
the viral load to undetectable levels thereby reducing the disease 
progression and the risk of transmission of the virus to others [20]. 
The proportion of non-adherence seen in this study, can result in 
massive drug resistance and reversal of the progress achieved in the 
control of the HIV epidemic [21, 22]. This will pose an additional 
financial burden on the already limited health resources. 
  
There was high drug availability, though 5 (1.8%) participants, 2 from 
the non-adherent group and 3 from the adherent group, reported 
being turned back without treatment due to drug unavailability. The 
following factors were associated with adherence in this study: 
improved health status, stigma, running out of medical supplies and 
forgetting to take treatment. Improved health status affected the 
participants' adherence to treatment in that they stopped taking their 
medication [23]. Our results were similar to those of Charurat et 
al. 2010, in a study done in Nigeria that reported that improved health 
could result in non-adherence if people believed they had been cured 
[24]. About two third (62.63%) of patients reported having good 
feeling, while 22% reported feeling bad about their status. While we 
acknowledge that stigma has been widely reported as a factor for 
non-adherence, in our study this did not come out clearly. As found 
in other studies, stigma is likely to provoke discrimination, rejection 
and isolation of people living with HIV [25]. It can also contribute to 
low rate of disclosure and thus poor adherence [25, 26]. In our study, 
we found a high percentage of disclosure (75.8%). This suggests that 
the study participants are generally accepting their condition and 
fears of stigma do not impact their retention and or adherence to 
treatment. Other research suggests that fear of stigma and 
discrimination influence some patients avoid going to hospital to 
replenish their drug supply and thus interrupt their treatment [15]. 
  
However, we believe that stigma, in this study, created emotional 
distress that resulted in some patients drinking and smoking heavily, 
as a way of providing some self-comfort. For instance, adherence to 
treatment was relatively higher among non-drinkers (89.4%), 
compared to drinkers (83.2%). In other words, alcohol consumption 
was associated with lower levels of adherence to ART among patients. 
However, in the final covariate adjusted model, we found very little 
evidence that poor adherence was ever affected by alcohol drinking 
status. A better alternative was to consider including alcohol intake 
frequency in the model, but this was not done simply because of low 
records at the lower stratification (no alcohol intake, daily, weekly). 
Nevertheless, the study showed some association between alcohol 
intake status and poor adherence to treatment. Better data could 
spark such evidence. Kekwaletswe et al. 2014 had similar findings, 
which supports the hypothesis that alcohol consumption is associated 
with low levels of ART adherence [27]. Another disadvantage of this 
habit is that patients may forget to take their medication because of 
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alcohol misuse. Men may also indulge in alcohol to deny the reality of 
being HIV-positive [28]. In this population those that failed to adhere 
to treatment were higher in the more educated groups, those with 
secondary (13.79%) and tertiary (33.3%) education compared to 
those without education (7.0%). This is different from the observation 
in most other studies that reported non-adherence among individuals 
with lower levels of education [29]. However, others had findings 
similar to ours [30]. Being educated does not mean that an individual 
is equipped with relevant knowledge relating to ART but this 
knowledge can be acquired through patient and health care provider 
interactions [31]. This was supported by a study conducted in Malawi 
that reported that appropriate health education was a useful 
approach to increasing patient's adherence because patients were 
taught about proper ART guidelines before they were commenced on 
medication [32]. 
  
From our study, we also found a statistically significant association 
between illness in the past month and poor adherence to ART. Among 
the patients who failed to adhere to treatment, those that 
experienced mild and severe illness were found at a higher likelihood 
of suboptimal adherence than those who were healthy. According to 
a study conducted by Markos et al. 2008, having symptoms in the 
past one month was associated with non-adherence, which is in line 
with our findings [33]. Another factor that was found to have a 
significant association with poor adherence to ART was the use of 
reminders to take medication. Most research reports that patients 
who use reminders to take medication were more likely to have better 
adherence than those who did not use any reminders [16, 34, 35]. 
Patients who use memory aids were three times more likely to adhere 
to treatment than those who did not use any memory aids [34]. 
Among the adherent group in our study, those that use reminders to 
take treatment (91.7%) were more adherent than those that did not 
use any reminders (85.3%). This suggests that patients should be 
encouraged to use reminders regularly to ensure that they take 
medications as prescribed [36]. However, among the non-adherent 
group, those that used reminders to take treatment (8.3%), adhered 
less compared to those that did not use any reminder (14.7%). This 
suggests that other factors are involved, other than having reminders 
among the non-adherents. This study was based on self-reported 
data on missed doses. Self-reports are subject to social desirability 
and recall bias [37] as evidenced by previous literature showing that 





The prevalence of adherence to ART in this study (87.0%) was 
unsatisfactory, though higher than the Limpopo provincial rate 
(61.0%), it was less than the 95% recommended by WHO. The study 
also revealed that the following factors were negatively associated 
with ART adherence: improved health status, stigma, running out of 
medication, forgetting to take treatment, illness and lack of facilities 
for treatment reminders. These factors need to be addressed to 
alleviate concerns of drug resistance and the resultant heavy financial 
burden on the health systems from the need to control resistant 
strains of HIV. Another negative implication of poor adherence is total 
treatment failure with increased morbidity and mortality. Efforts by 
health care providers must be improved in counselling at initiation 
and during follow-up hospital visits. The health care providers should 
regularly counsel and educate patients before initiation and during 
the course of ART. The counselling sessions should emphasize on the 
nature of the HIV disease, characteristics of HIV medication, benefits 
of ART, the importance of adherence, the goal of the treatment, and 
the risks of non-adherence to ART. However, this requires a concerted 
effort among the multidisciplinary team, including adherence 
counsellors. 
  
What is known about this topic 
 There is increasing access to ART program among HIV 
positive individuals and with it comes the challenge of 
treatment adherence; 
 Adherence to ART among HIV positive individuals is a key 
success factor as it enhances viral suppression, decreases 
the risk of HIV transmission, reduces the risk of ART drug 
resistance and improves the quality of life. 
What this study adds 
 Adherence to ART in this study was unsatisfactory, though 
higher than the previously reported rate for the Limpopo 
provincial rate, it was lower than the rate recommended by 
the WHO; 
 Factors that were negatively associated with ART 
adherence among individuals attending care at Letaba 
hospital included ‘improved health status, HIV related 
stigma, running out of medication, lack of facilities for 
treatment reminders’ among individuals in HIV care; 
 The need to reinforce information, education and 
communication practices in this setting in order to expand 
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awareness and knowledge regarding negative effect of 
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Table 1: sociocultural and demographic characteristic of 
the study participants 
Characteristics Frequency % 
Age 
  
18 - 23 110 39.2 
24 - 29 112 39.8 
30 - 35 59 21.0 
Gender 
  
Male 118 42.0 
Female 163 58.0 
Marital Status 
  
Single / Divorce / Widow 168 59.8 
In union 113 40.2 
Religion 
  
Christians 141 50.2 
Others 140 49.8 
Language 
  
Xitsonga 160 56.9 
Sepedi 111 39.5 
Others 10 3.6 
Education 
  
None 43 15.3 
Primary 81 28.8 
Secondary 145 51.6 
Tertiary 12 4.3 
Employment Status 
  
Unemployed 215 76.5 
Employed 66 23.5 
Income Categories 
  
No Income 167 59.4 
R100 - R2999 94 33.5 
R3000 -R10000 20 7.1 
Distance from Healthcare 
Facility 
  
< 5Km 93 33.1 
5-10Km 160 56.9 
11-20Km 28 10.0 
Alcohol Status 
  
Non drinker 180 64.1 
Drinker 101 35.9 
Smoking Status 
  
Non Smoker 221 78.7 
Smoker 60 21.3 
 
















































Table 2: patients related and environmental factors 
Patients related factors Frequency % 
Method of reminder 
  
None 197 70.1 
Alarm 35 12.5 
TV 38 13.5 
Friend 11 3.9 
Disclosure 
  
No 68 24.2 
Yes 213 75.8 
Feeling status 
  
Bad 64 22.8 
Fair 41 14.6 
Good 176 62.6 
Duration under ART 
  
< 1 year 63 22.4 
1 - 2 years 28 10.0 
2 years + 190 67.6 
Failed adherence 
  
No 245 87.2 
Yes 36 12.8 
Reported side effects 
  
No 250 89.0 
Yes 31 11.0 
Illness severity 
  
None 250 89.0 
Mild 23 8.2 
Severe 8 2.8 
ART change 
  
No 163 58.0 
Yes 118 42.0 
Illness 
  
No 245 87.2 
Yes 36 12.8 
Attitude 
  
Negative 20 7.1 
Positive 261 92.9 
Waiting time (queuing) 
  
< 1 hour 163 58.0 
1 - 2 hours 112 39.9 
2 - 3 hours 6 2.1 
Use of reminder 
  
No 197 70.1 
Yes 84 29.9 
 










































Table 3: univariate analysis of factors associated with poor adherence to antiretroviral 
treatment 




   
18 – 23 16 (14.6) 94 (85.4) 0.296 
24 – 29 16 (14.3) 96 (85.7) 
30 – 35 4 (  6.8) 55 (93.2) 
Gender 
   
Male 18 (15.2) 100 (84.8) 0.297 
Female 18 (11.0) 145 (89.0) 
Marital status 
   
Single / Divorce / Widow 21 (12.5) 147 (87.5) 0.849 
In union 15 (13.3) 98 (86.7) 
Education 
   
None 3 (  7.0) 40  (93.0) 0.104 
Primary 9 (11.1) 72  (88.9) 
Secondary 20 (13.8) 125 (86.2) 
Tertiary 4 (33.3) 8 ( 66.7) 
Distance from healthcare facility 
   
< 5Km 12 (12.9) 81 (87.1) 0.939 
5-10Km 21 (13.1) 139 (86.9) 
11-20Km 3 (10.7) 25 (89.3) 
Disclosure status 
   
No 10 (14.7) 58 (85.3) 0.591 
Yes 26 (12.2) 187 (87.2) 
Duration of treatment 
   
< 1 year 10 (15.9) 53 (84.1) 0.261 
1 – 2 years 1 (3.6) 27 (96.4) 
2 years + 25 (13.2) 165 (86.8) 
Side effects 
   
No 30 (12.0) 220 (88.0) 0.248 
Yes 6 (19.4) 25 (80.6) 
Disease severity 
   
None 30 (12.0) 220 (88.0) 0.084 
Mild 6 (26.1) 17 (73.9) 
Severe 0 (0.0) 8 (100.0) 
ART change 
   
No 21 (12.9) 142 (87.1) 0.966 
Yes 15 (12.7) 103 (87.3) 
Drug unavailability 
   
Yes 34 (12.3) 242 (87.7) 0.066 
No 2 (40.0) 3 (60.0) 
 






























Table 4: likelihood for adherence using selected socio-demographic and clinical 
factors (odds ratio and 95% Confidence Intervals) 




OR (95% C.I) OR (95% C.I) 
Age Category     
<25 Ref Ref 
25-29 0.90 (0.42-1.93) 0.73 (0.30-1.76) 
30-35 0.41 (0.13-1.27) 0.28 (0.07-1.17) 
Education     
None Ref Ref 
Primary 1.67 (0.43-6.51) 0.74 (0.15-3.71) 
Secondary 2.13 (0.60-7.56) 1.15 (0.27-4.85) 
Tertiary 6.67 (1.24-35.71) 5.85 (1.02-34.47) 
Reminders     
No Ref Ref 
Yes 0.53 (0.22-1.25) 0.53 (0.22-1.31) 
Severity of sickness     
No Ref Ref 
Yes 1.11 (0.40-3.08) 1.29 (0.44-3.81 
Alcohol Consumption     
No Ref Ref 
Yes 1.71 (0.85-3.47) 1.70 (0.80-3.59) 
Use of Reminder     
No Ref Ref 
Yes 0.53 (0.22-1.25) 0.53 (0.22-1.31) 
Drug Unavailability     
No Ref Ref 
Yes 4.75 (0.77-29.43) 3.56 (0.50-25.49) 
Distance to health 
facility 
    
< 5Km Ref Ref 
1-10Km 1.02 (0.48-2.18) 1.10 (0.49-2.46) 
11-20Km 0.81 (0.21-3.10) 1.02 (0.24-4.35 
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Figure 2: adherence prediction using a combined effect of disease severity and drug availability 
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Figure 3: adherence prediction using the effect of distance to health facility 
 
